← Back to Search

Behavioral Intervention

CO-OP Group for Concussion

N/A

Waitlist Available

Led By Anna Boone, PhD

Research Sponsored by University of Missouri-Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up post-intervention only (10 weeks post-baseline)

Awards & highlights

Study Summary

This trial will test how well a cognitive strategy training intervention works in adults with post-concussive syndrome.

Eligible Conditions

Concussion
Post-Concussion Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post-intervention only (10 weeks post-baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post-intervention only (10 weeks post-baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention only (10 weeks post-baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Client Satisfaction Questionnaire-8

adherence rate

assessment battery feasibility

+2 more

Secondary outcome measures

Canadian Occupation Performance Measure (COPM)

College of Optometrists in Vision Quality of Life Outcomes Assessment (COVD-QOL)

Dysexecutive Questionnaire

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: CO-OP GroupExperimental Treatment1 Intervention

10, 45-60 minute Cognitive Orientation to daily Occupational Performance intervention sessions

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CO-OP Group

2020

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor

361 Previous Clinical Trials

627,979 Total Patients Enrolled

Anna Boone, PhD3.02 ReviewsPrincipal Investigator - University of Missouri-Columbia

University of Missouri-Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I register to take part in this clinical research?

"Eligibility requirements for the trial necessitate that potential enrollees must have suffered a brain concussion and be aged between 18-60. In total, 15 patients will be admitted to the project."

Answered by AI

Are there any vacancies left in this investigation for participants?

"Per the information posted on clinicaltrials.gov, this trial is actively enrolling patients. It was initially advertised on October 15th 2020 and modified most recently on February 9th 2022."

Answered by AI

Is this clinical trial available to persons of an advanced age?

"The age limits of this trial restrict it to individuals aged 18-60. Patients under the age of 18 have 406 studies available, while those over 65 may participate in 1027 trials."

Answered by AI

What primary objectives have been established for this research effort?

"Primarily, this trial seeks to measure long-term retention rate at 10 weeks post intervention. Secondary objectives encompass the College of Optometrists in Vision Quality of Life Outcomes Assessment (COVD-QOL) which assesses visual impairment impacts on quality of life with a five point Likert scale; Henry Ford Hospital Headache Disability Inventory for analyzing headache symptom impact using self-report questionnaires and Pittsburgh Sleep Quality Index that evaluates sleep patterns and quality through a four point Likert scale."

Answered by AI

How many participants are actively engaged in this research endeavor?

"Indeed, according to clinicaltrials.gov the trial, which was initially advertised on October 15th 2020 is still recruiting patients. The researchers hope for a total of 15 participants from 1 medical centre."

Answered by AI